MEASURING EFFICIENCY OF PHARMACEUTICAL COMPANIES OF THE REPUBLIC OF UZBEKISTAN
Main Article Content
Аннотация:
This paper presents a Data Envelopment analysis (DEA) for measuring efficiency of pharmaceutical companies. Letting each of fifteen companies in each year be a separate decision-making unit, and utilizing three inputs and one output, we measure annual efficiency values, slacks and target units of Uzbek local pharmaceutical companies for decade 2010-2019 as defined by the period of variables. Measuring efficiencies for every year together with slack values and suggested target monetary values, we empirically show that on average 5 firms (Reka med, Dentafil, Torimed pharm, SEEM and Uzgermed) out of 15 were inefficient every year. However, inefficiency was not significant, varying around 0.80-0.99. Throughout the study decade, most frequent slacks were depicted in excess input utilization rather than output usage.
Article Details
Как цитировать:
Библиографические ссылки:
Abdurakhmonov, J. U. Research of the pharmaceutical market of Uzbekistan and prospects of its development / J. U. Abdurakhmonov O. M. Voronina // Topical issues of new drugs development : abstracts оf XXIV international scientific and practical conference of young scientists and student, April 20, 2017. - Kh., 2017. - Vol. 2. - P. 193-194.
VAYTON (2019). Pharmaceutical market of Uzbekistan. [online] Slideshare.net. Available at: https://www.slideshare.net/vaytonbrandcapital/pharmaceutical-market-of-uzbekistan [Accessed 14 Oct. 2019].
Akihiro Hashimoto, Shoko Haneda Measuring the change in R&D efficiency of the Japanese
pharmaceutical industry / Research Policy 37 (2008) 1829–1836
Honjo, Y., Haneda, S.: R&D evaluation of Japanese pharmaceutical firms using DEA. J. Sci. Policy Res. Manag. 13, 96–105 (1998))).
Taewoo Youa,*, Xiaoying Chenb and Mark E. Holder Efficiency and its determinants in pharmaceutical industries: ownership, R&D and scale economy Applied Economics, 2010, 42, 2217–2241
Mao, Y., Li, J., Liu, Y.: Evaluating business performance of China’s pharmaceutical companies based on data envelopment analysis. Stud. Ethno Med. 8, 51–60 (2014)
